| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/26/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 90k | $23.57 | $2.1M | | 02/26/2021 |
| 02/26/2021 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 12k | $0.00 | $0 | | 02/26/2021 |
| 02/28/2020 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 85k | $7.80 | $663k | | 02/28/2020 |
| 06/20/2019 | PDL BIOPHARMA, INC. | PDLI | Grant | Stock Option (right to buy) | 126k | $3.00 | $378.2k | | 06/20/2019 |
| 05/15/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 45k | $10.80 | $486k | | 05/15/2019 |
| 02/28/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Common Stock | 2.5k | $0.00 | $0 | | 02/28/2019 |
| 02/28/2019 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 15k | $8.02 | $120.3k | | 02/28/2019 |
| 06/12/2018 | Tonix Pharmaceuticals Holding Corp. | TNXP | Grant | Stock Option | 20k | $4.25 | $85k | | 06/12/2018 |
| 06/08/2018 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 54.3k | $2.76 | $150k | | 06/08/2018 |
| 05/31/2018 | Protagonist Therapeutics, Inc | PTGX | Grant | Stock Option (right to buy) | 50k | $7.28 | $364k | | 05/31/2018 |
| 06/09/2017 | PDL BIOPHARMA, INC. | PDLI | Grant | Common stock | 60.7k | $2.47 | $150k | | 06/09/2017 |
| 05/27/2017 | Tonix Pharmaceuticals Holding Corp. | TNXP | Exercise | Restricted Stock Units | 750 | $0.00 | $0 | | 02/25/2016 |
| 02/09/2017 | Tonix Pharmaceuticals Holding Corp. | TNXP | Exercise | Restricted Stock Units | 750 | $0.00 | $0 | | 02/25/2016 |
| 02/25/2016 | Tonix Pharmaceuticals Holding Corp. | TNXP | Exercise | Restricted Stock Units | 650 | $0.00 | $0 | | 02/25/2016 |